导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.37% | 380/1050 |
| 近一周 | -2.08% | 716/1104 |
| 近一月 | -5.09% | 772/1103 |
| 近一季 | -6.29% | 536/1092 |
| 近半年 | 5.21% | 335/1070 |
| 近一年 | 7.75% | 419/1018 |
| 近两年 | 54.45% | 485/926 |
| 近三年 | 31.47% | 389/834 |
| 成立以来 | 69.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.24% 729/1070 |
24.94% 336/1101 |
- - |
- - |
| 2025 | 20.30% 666/1065 |
-1.20% 872/1014 |
4.71% 315/1038 |
18.99% 634/1050 |
-2.28% 575/1065 |
| 2024 | 11.86% 245/1011 |
3.18% 161/960 |
-0.46% 337/983 |
12.34% 431/991 |
-3.06% 543/1011 |
| 2023 | -10.13% 336/952 |
2.43% 480/880 |
-2.08% 306/895 |
-3.19% 216/915 |
-7.45% 721/952 |
| 2022 | -21.95% 405/867 |
-16.84% 353/773 |
8.34% 338/806 |
-14.04% 516/845 |
0.78% 404/867 |
| 2021 | 1.01% 345/740 |
-1.91% 221/580 |
14.08% 255/659 |
-8.43% 462/704 |
-1.43% 490/740 |
| 2020 | 52.65% 227/554 |
-5.43% 303/419 |
22.61% 236/466 |
12.91% 182/517 |
16.60% 177/554 |
| 2019 | 46.06% 177/410 |
24.00% 784/1146 |
0.61% 275/1228 |
5.37% 195/390 |
11.11% 130/410 |
| 2018 | -19.85% 75/349 |
- - |
-6.46% 229/990 |
-1.39% 262/1000 |
-10.80% 367/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 华夏研究精选股票 VS. 东吴新产业精选股票A(580008) |